Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting

Area of Science:

• Cardiology
• Biomarkers
• Interventional Cardiology

Background:

• Inflammatory markers, including C-reactive protein (CRP), serum amyloid A protein (SAA), and interleukin-6 (IL-6), are known predictors of coronary restenosis in unstable angina patients post-angioplasty and stent deployment.
• The predictive value of these markers in stable angina patients undergoing coronary stenting remains less understood.

Purpose of the Study:

• To investigate whether periprocedural inflammatory markers (CRP, SAA, IL-6) predict the angiographic outcome at 6 months in stable angina patients undergoing coronary stenting.
• To determine the correlation between preprocedural inflammatory marker levels and the development of in-stent restenosis.

Main Methods:

• A prospective study involving 182 patients, with 152 undergoing elective coronary stenting and 30 serving as a control group undergoing diagnostic angiography.
• High-sensitivity immunoassays were used to measure CRP, SAA, and IL-6 levels pre- and post-procedure.
• Quantitative computer-assisted angiographic analysis was performed at 6 months to assess binary restenosis rates.

Main Results:

• A binary restenosis rate of 33.8% was observed at 6 months in 133 patients who received stents.
• No significant differences were found in pre- or post-procedure CRP, SAA, or IL-6 levels between patients with and without in-stent restenosis.
• A high percentage of patients (80%) were on statin therapy.

Conclusions:

• Preprocedural inflammatory markers do not correlate with the development of in-stent restenosis in stable angina patients undergoing coronary artery stent deployment.
• Differences in the pathobiology of stable versus unstable coronary syndromes, the impact of statin therapy, and distinct mechanisms of early restenosis may explain the findings.